<p>，/PRNewswire/ -- Moyom Biotechnology 最近宣布与全球领先的传播与创意网络之一 WPP Group 建立战略合作伙伴关系。该合作伙伴关系以 “时间的诗学” 品牌框架为中心，专注于 Aphranel 全球品牌传播的长期演变。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Moyom Biotechnology 宣布与 WPP Group 建立战略合作伙伴关系</p>
<p>WPP Group 总部位于伦敦，在全球 100 多个国家运营，整合了创意、媒体、公关、数字、咨询和人工智能等领域的能力。通过此次合作，WPP 将利用其全球资源和综合专业知识，帮助 Aphranel 建立清晰、一致且具有国际相关性的市场准备品牌叙事，同时向更广泛的专业受众传达 “时间的诗学” 背后的价值观及其科学和临床方法。</p>
<p>Aphranel 是 Moyom Biotechnology 的核心品牌，定位为中国首个获得监管批准的基于 CaHA 的再生注射剂。该品牌的定义基于回归核心医学原则的理念，强调结构支持和与自然时间节奏相一致的长期生物过程。</p>
<p>“时间的诗学” 反映了 Aphranel 的信念，即美学医学应超越抵抗衰老的概念，而应专注于尊重解剖学、材料科学和长期临床价值。与 WPP 的合作代表了在再生科学与基于临床的、时间导向的医学哲学交汇处加强品牌全球表达的关键一步。</p>
<p>Moyom Biotechnology 表示，将继续与 WPP 合作，扩大 Aphranel 的国际影响力，并进一步在全球市场建立长期品牌信任和一致性。</p>
<p>关于 Aphranel</p>
<p>Aphranel 是 Moyom Biotechnology 的核心品牌，专注于临床使用的专业医学美学应用。该品牌专注于面部注射剂和再生材料，致力于基于科学的发展和对长期临床价值的持续承诺。</p>
<p>关于 Moyom Biotechnology</p>
<p>Moyom Biotechnology 是一家致力于再生材料和专业医学美学的医疗技术公司，专注于基于科学的解决方案和可持续的医疗创新。</p>
<p>关于 WPP</p>
<p>WPP 是全球最大的广告和营销服务集团，提供全球范围内的综合品牌、媒体、公关、数据和技术解决方案。</p>
<p>来源：上海 Moyom Biotechnology Co., Ltd</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTI2Jk5ld3NJdGVtSWQ9Q043MDU4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjYwMDU2UFJfTkVXU19VU1BSX19fX19DTjcwNTg3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTI2Jk5ld3NJdGVtSWQ9Q043MDU4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjYwMDU2UFJfTkVXU19VU1BSX19fX19DTjcwNTg3"/></p>

NNNN

美国医药设备 ETF - iShares

SANA

生物科技 ETF - VanEck Vectors

纽交所高增长板生物技术指数 ETF - First Trust

医药突破 ETF - ALPS

IBBQ

标普生物技术 ETF - SPDR

动态生物技术与基因组 ETF - Invesco

<p>Moyom Biotechnology 宣布与 WPP Group 建立战略合作伙伴关系，以提升 Aphranel 的 “时间的诗学” 框架的全球品牌定位。此次合作旨在建立一个一致且具有国际相关性的品牌叙事，强调 Aphranel 背后的科学和临床价值，Aphranel 是中国首个获得批准的基于 CaHA 的再生注射剂。WPP 将利用其全球资源扩大 Aphranel 的影响力，并在各个市场建立长期的品牌信任，专注于尊重解剖学和在美学医学中长期临床价值的理念</p>

<p>, /PRNewswire/ -- Moyom Biotechnology recently announced a strategic partnership with WPP Group, one of the world's leading global communications and creative networks. The partnership is centered on the &#34;Poetics of Time&#34; brand framework and will focus on the long-term evolution of Aphranel's global brand communications.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Moyom Biotechnology 最近宣布与全球领先的传播与创意网络之一 WPP Group 建立战略合作伙伴关系。该合作伙伴关系以 “时间的诗学” 品牌框架为中心，专注于 Aphranel 全球品牌传播的长期演变。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Moyom Biotechnology Announces Strategic Partnership with WPP Group</p>
<div class="lb-trans"><p>Moyom Biotechnology 宣布与 WPP Group 建立战略合作伙伴关系</p>
</div><p>Headquartered in London, WPP Group operates in more than 100 countries worldwide, integrating capabilities across creative, media, public relations, digital, consulting, and artificial intelligence. Through the partnership, WPP will draw on its global resources and integrated expertise to help Aphranel establish a clear, consistent, and internationally relevant, market-ready brand narrative, while communicating the values and the underlying scientific and clinical approach behind Poetics of Time to a broader professional audience.</p>
<div class="lb-trans"><p>WPP Group 总部位于伦敦，在全球 100 多个国家运营，整合了创意、媒体、公关、数字、咨询和人工智能等领域的能力。通过此次合作，WPP 将利用其全球资源和综合专业知识，帮助 Aphranel 建立清晰、一致且具有国际相关性的市场准备品牌叙事，同时向更广泛的专业受众传达 “时间的诗学” 背后的价值观及其科学和临床方法。</p>
</div><p>Aphranel is a core brand of Moyom Biotechnology, positioned as the first CaHA-based regenerative injectable to receive regulatory approval in China. The brand is defined by an approach centered on a return to core medical principles, emphasizing structural support and long-term biological processes aligned with the natural rhythm of time.</p>
<div class="lb-trans"><p>Aphranel 是 Moyom Biotechnology 的核心品牌，定位为中国首个获得监管批准的基于 CaHA 的再生注射剂。该品牌的定义基于回归核心医学原则的理念，强调结构支持和与自然时间节奏相一致的长期生物过程。</p>
</div><p>&#34;Poetics of Time&#34; reflects Aphranel's belief that aesthetic medicine should move beyond the notion of resisting aging, and instead focus on respecting anatomy, material science, and long-term clinical value. The partnership with WPP represents a key step in strengthening the brand's global expression at the intersection of regenerative science and a clinically grounded, time-based medical philosophy.</p>
<div class="lb-trans"><p>“时间的诗学” 反映了 Aphranel 的信念，即美学医学应超越抵抗衰老的概念，而应专注于尊重解剖学、材料科学和长期临床价值。与 WPP 的合作代表了在再生科学与基于临床的、时间导向的医学哲学交汇处加强品牌全球表达的关键一步。</p>
</div><p>Moyom Biotechnology said that it will continue working with WPP to expand the international reach of Aphranel and further build long-term brand trust and consistency across global markets.</p>
<div class="lb-trans"><p>Moyom Biotechnology 表示，将继续与 WPP 合作，扩大 Aphranel 的国际影响力，并进一步在全球市场建立长期品牌信任和一致性。</p>
</div><p>About Aphranel</p>
<div class="lb-trans"><p>关于 Aphranel</p>
</div><p>Aphranel is a core brand of Moyom Biotechnology, focused on professional medical aesthetics applications for clinical use. The brand specializes in facial injectables and regenerative materials, driven by science-based development and a sustained commitment to long-term clinical value.</p>
<div class="lb-trans"><p>Aphranel 是 Moyom Biotechnology 的核心品牌，专注于临床使用的专业医学美学应用。该品牌专注于面部注射剂和再生材料，致力于基于科学的发展和对长期临床价值的持续承诺。</p>
</div><p>About Moyom Biotechnology</p>
<div class="lb-trans"><p>关于 Moyom Biotechnology</p>
</div><p>Moyom Biotechnology is a medical technology company dedicated to regenerative materials and professional medical aesthetics, with a focus on science-based solutions and sustainable innovation in healthcare delivery.</p>
<div class="lb-trans"><p>Moyom Biotechnology 是一家致力于再生材料和专业医学美学的医疗技术公司，专注于基于科学的解决方案和可持续的医疗创新。</p>
</div><p>About WPP</p>
<div class="lb-trans"><p>关于 WPP</p>
</div><p>WPP is the world's largest advertising and marketing services group, providing integrated brand, media, public relations, data, and technology solutions worldwide.</p>
<div class="lb-trans"><p>WPP 是全球最大的广告和营销服务集团，提供全球范围内的综合品牌、媒体、公关、数据和技术解决方案。</p>
</div><p>SOURCE SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD</p>
<div class="lb-trans"><p>来源：上海 Moyom Biotechnology Co., Ltd</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTI2Jk5ld3NJdGVtSWQ9Q043MDU4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjYwMDU2UFJfTkVXU19VU1BSX19fX19DTjcwNTg3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CN70587&amp;Transmission_Id=202601260056PR_NEWS_USPR_____CN70587&amp;DateId=20260126"/></p>

00:56 ET
			
			
				Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning

prnewswire

Anbio Biotechnology

Sana Biotechnology

Invesco Nasdaq Biotechnology ETF

Moyom Biotechnology 宣布与 WPP 集团建立战略合作伙伴关系，以提升 Aphranel 的 “时间的诗学” 品牌定位